| Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries T Zhao, W Wu, L Sui, Q Huang, Y Nan, J Liu, K Ai Bioactive Materials 7, 47-72, 2022 | 227 | 2022 |
| MoS2-based nanocomposites for cancer diagnosis and therapy J Wang, L Sui, J Huang, L Miao, Y Nie, K Wang, Z Yang, Q Huang, ... Bioactive Materials 6 (11), 4209-4242, 2021 | 198 | 2021 |
| Preparative isolation and purification of seven main antioxidants from Eucommia ulmoides Oliv.(Du-zhong) leaves using HSCCC guided by DPPH-HPLC experiment X Dai, Q Huang, B Zhou, Z Gong, Z Liu, S Shi Food Chemistry 139 (1-4), 563-570, 2013 | 182 | 2013 |
| Emerging sonodynamic therapy‐based nanomedicines for cancer immunotherapy Y Yang, J Huang, M Liu, Y Qiu, Q Chen, T Zhao, Z Xiao, Y Yang, Y Jiang, ... Advanced Science 10 (2), 2204365, 2023 | 124 | 2023 |
| Rheumatoid arthritis microenvironment insights into treatment effect of nanomaterials Y Zhu, T Zhao, M Liu, S Wang, S Liu, Y Yang, Y Yang, Y Nan, Q Huang, ... Nano Today 42, 101358, 2022 | 108 | 2022 |
| Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair JY Yin, J Shen, ZZ Dong, Q Huang, MZ Zhong, DY Feng, HH Zhou, ... Clinical cancer research 17 (13), 4600-4609, 2011 | 94 | 2011 |
| Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney Q Chen, Y Nan, Y Yang, Z Xiao, M Liu, J Huang, Y Xiang, X Long, T Zhao, ... Bioactive materials 22, 141-167, 2023 | 85 | 2023 |
| Lipid-tuned Zinc Transport Activity of Human ZnT8 Protein Correlates with Risk for Type-2 Diabetes*♦ C Merriman, Q Huang, GA Rutter, D Fu Journal of Biological Chemistry 291 (53), 26950-26957, 2016 | 84 | 2016 |
| IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population Q Huang, J Yin, X Dai, Q Pei, M Dong, Z Zhou, X Huang, M Yu, H Zhou, ... Acta Pharmacologica Sinica 31 (6), 709-717, 2010 | 83 | 2010 |
| Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphisms in Chinese population JY Yin, Q Huang, Y Yang, JT Zhang, MZ Zhong, HH Zhou, ZQ Liu Pharmacogenetics and genomics 19 (3), 206-216, 2009 | 79 | 2009 |
| KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) Polymorphisms Affect Therapeutic Efficacy of Repaglinide in Chinese Patients With Type 2 Diabetes M Yu, XJ Xu, JY Yin, J Wu, X Chen, ZC Gong, HY Ren, Q Huang, ... Clinical Pharmacology & Therapeutics 87 (3), 330-335, 2010 | 77 | 2010 |
| Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients Q Huang, JY Yin, XP Dai, J Wu, X Chen, CS Deng, M Yu, ZC Gong, ... European journal of clinical pharmacology 66, 1207-1215, 2010 | 76 | 2010 |
| PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China Q Pei, Q Huang, G Yang, Y Zhao, J Yin, M Song, Y Zheng, Z Mo, H Zhou, ... Acta Pharmacologica Sinica 34 (2), 255-261, 2013 | 73 | 2013 |
| State of the art advancements in sonodynamic therapy (SDT): Metal-Organic frameworks for SDT Z Xiao, Q Chen, Y Yang, S Tu, B Wang, Y Qiu, Y Jiang, Q Huang, K Ai Chemical Engineering Journal 449, 137889, 2022 | 72 | 2022 |
| Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19 L Chen, Q Huang, T Zhao, L Sui, S Wang, Z Xiao, Y Nan, K Ai Redox biology 45, 102046, 2021 | 72 | 2021 |
| Oral metal‐free melanin nanozymes for natural and durable targeted treatment of inflammatory bowel disease (IBD) Q Huang, Y Yang, Y Zhu, Q Chen, T Zhao, Z Xiao, M Wang, X Song, ... Small 19 (19), 2207350, 2023 | 70 | 2023 |
| Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients JY Yin, Q Huang, YC Zhao, HH Zhou, ZQ Liu PloS one 7 (6), e38150, 2012 | 68 | 2012 |
| Emerging early diagnostic methods for acute kidney injury Z Xiao, Q Huang, Y Yang, M Liu, Q Chen, J Huang, Y Xiang, X Long, ... Theranostics 12 (6), 2963, 2022 | 65 | 2022 |
| Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study X Hu, J Du, Y Xie, Q Huang, Y Xiao, J Chen, S Yan, Z Gong, S Ouyang BMC nephrology 21, 1-12, 2020 | 64 | 2020 |
| Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant‐induced arthritis D Wang, S Hu, J Zhu, J Yuan, J Wu, A Zhou, Y Wu, W Zhao, Q Huang, ... Journal of cellular and molecular medicine 17 (12), 1577-1587, 2013 | 61 | 2013 |
